![]() People with a history of diabetes or at risk of diabetes should be monitored closely. Blood levels may need monitoring as Aristada can cause the numbers of white blood cells to decrease.May not be suitable for people with known cardiovascular disease (history of a heart attack, angina, heart failure, or arrhythmia), stroke, seizure disorders, and people at risk of dehydration. This may cause a drop in blood pressure on standing, particularly during the initial dose-titration period, which may increase the risk of falls and the dosage of Aristada may need to be reduced.May increase the risk of suicidal thoughts or behavior (similar to other antidepressants and antipsychotics). Monitor for any adverse mood effects, such as worsening depression, agitation, or mood changes.Not approved for and should not be used to treat dementia-related psychosis in elderly people as associated with a higher risk of death.Can only be administered by a health professional. ![]() Discontinue Aristada in those with severe neutropenia (absolute neutrophil count /sup>). Other side effects including changes in white blood cell counts have also been reported.Some patients may not recognize these urges as abnormal so prescribers should ask them or their caregivers about them. Research has also shown that some patients can experience intense urges, particularly for gambling, while taking Aristada.Akathisia (inner restlessness), headache, injection site pain, insomnia, increased blood creatine phosphokinase levels, and increased weight are the most common side effects reported.If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include: An injection of Aristada is given at the same time or within 10 days. Oral aripiprazole should be given in conjunction with the first injection of Aristada for 21 consecutive days unless Aristada Initio is used (this contains one loading-dose injection of aripiprazole lauroxil which is given in conjunction with one 30mg aripiprazole tablet.When switching from Abilify Maintena start Aristada 882mg four weeks after the last Abilify Maintena 400mg IM injection.Can be administered as 441mg, 662mg, or 882mg given every 4 weeks: 882mg given every 6 weeks or 1064mg given once every 2 months.Aristada is administered via an intramuscular (IM) injection into the deltoid muscle (441mg dose only) or the gluteal muscle (441mg, 662mg, 882mg, or 1064mg).Each kit contains a 5-mL prefilled syringe containing aripiprazole lauroxil in a sterile aqueous suspension, as well as safety needles. Available in 3 strengths: 441 mg in 1.6 mL, 662 mg in 2.4 mL, and 882 mg in 3.2 mL.Available as a ready-to-use, prefilled syringe but must be administered by a healthcare professional.EPS are drug-induced movement disorders and include tremors, Parkinson's-like symptoms (walking with a shuffle, mask-like facial features), and tardive dyskinesia (this describes abnormal, repetitive facial movements such as lip-smacking or poking the tongue out). ![]() This means it is less likely than older antipsychotics to cause side effects, such as extrapyramidal symptoms (EPS).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |